Publication | Open Access
Influence Of Promoter Polymorphisms Of The Tnf-α (-308g/A) And IL-6 (-174g/C) Genes On Therapeutic Response To Etanercept In Rheumatoid Arthritis
24
Citations
25
References
2014
Year
The study suggests that patients who are genetically low TNF-α and IL-6 producers are the best responders to etanercept therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1